Establishment of a new laboratory test for radiation sensitivity targeting p53 signal transduction system
Establishment of a new laboratory test for radiation sensitivity targeting p53 signal transduction system
批准号:
20590580
负责人:
YAMADA Yasuaki
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although radiation therapy is one of the effective therapies for cancers, there are some patients who are extraordinarily sensitive to radiation in whom radiation-induced skin ulcer and perforation of gastro-intestinal tracts sometimes occur. Since there is no way to identify such radiation hypersensitive patients before therapy, we tried to establish a laboratory test for this purpose in the present study. Objects are mamma cancer patients who are planned to receive radiation therapy. Peripheral blood mononuclear cells were obtained from these patients before and after radiation. Radiation-induced skin damage was evaluated in all patients, but there was no significant difference among patients, indicating that radiation hypersensitive patients were not included in the study. Absolute peripheral blood lymphocyte count decreased in all patients after radiation, but absolute neutrophil count showed no changes. Interestingly, radiation sensitivity was different among lymphocyte subsets, and T lymphocytes were more sensitive than B lymphocyte or NK lymphocytes. CD8+ T-cell subset was the most sensitive lymphocytes and decrease of the absolute count prolonged even after 12 weeks after radiation. Nevertheless, increase of apoptotic lymphocytes was not observed in the peripheral blood. We then quantified mRNAs of various molecules that are supposed to be influenced by radiation, such as p53, p14ARF、p16INK4A and Hzf. There was however no significant correlation between the changes of the mRNA levels of these molecules and the level of the decrease of absolute lymphocyte counts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
ホームページ等。
主页等
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aberrant p53 protein expression and function in a panel of hematonoietic cell lines with different p53 mutations.
一组具有不同 p53 突变的造血细胞系中异常的 p53 蛋白表达和功能。
DOI:
--
发表时间:
2009
期刊:
European Journal of Haematology 82
影响因子:
--
作者:
[Kamihira S, et al.]
通讯作者:
et al.
成人T細胞白血病(ATLL)におけるEZH2高発現の病的意義。
成人 T 细胞白血病 (ATLL) 中 EZH2 高表达的病理意义。
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[佐々木大介, ほか]
通讯作者:
ほか
造血器細胞株におけるp53遺伝子変異とp53mRNA及び蛋白定量による発現の検討
通过定量造血细胞系中 p53 mRNA 和蛋白质来检查 p53 基因突变和表达
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[寺田千春、山田恭暉、上平憲, 他]
通讯作者:
他
Membrane-associated mucin MUC1 is overexpressed in adult T-cell leukemia/lymphoma cells and contributes to anti-apoptotic properties.
膜相关粘蛋白 MUC1 在成人 T 细胞白血病/淋巴瘤细胞中过度表达,并有助于抗凋亡特性。
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Hasegawa H, Yamada Y, Kamihira S, et al]
通讯作者:
et al
共 12 条
Molcular-target chemotherapy in ATL using MTAP-gene deficiency
-
批准号:10670956
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:YAMADA Yasuaki
-
依托单位:
THE INVOLVEMENT OF OXIDANT AND ANTIOXIDANT SYSTEM IN FAS-MEDIATED APOPTOSIS OF ATL CELLS.
-
批准号:07671214
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:YAMADA Yasuaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: